Schroder Investment Management Group raised its holdings in K2M Group Holdings, Inc. (NASDAQ:KTWO) by 0.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,574,831 shares of the medical device company’s stock after acquiring an additional 14,491 shares during the period. Schroder Investment Management Group owned about 3.63% of K2M Group worth $32,552,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of KTWO. Alliancebernstein L.P. grew its stake in K2M Group by 31.8% in the first quarter. Alliancebernstein L.P. now owns 35,190 shares of the medical device company’s stock valued at $722,000 after acquiring an additional 8,500 shares during the period. Teachers Advisors LLC grew its stake in K2M Group by 3.0% in the first quarter. Teachers Advisors LLC now owns 43,823 shares of the medical device company’s stock valued at $899,000 after acquiring an additional 1,286 shares during the period. Legal & General Group Plc grew its stake in K2M Group by 9.1% in the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after acquiring an additional 564 shares during the period. Vanguard Group Inc. grew its stake in K2M Group by 13.8% in the first quarter. Vanguard Group Inc. now owns 1,379,090 shares of the medical device company’s stock valued at $28,285,000 after acquiring an additional 167,036 shares during the period. Finally, Geode Capital Management LLC grew its stake in K2M Group by 10.7% in the first quarter. Geode Capital Management LLC now owns 275,498 shares of the medical device company’s stock valued at $5,650,000 after acquiring an additional 26,578 shares during the period. 98.22% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts have issued reports on KTWO shares. Needham & Company LLC reissued a “strong-buy” rating and issued a $27.00 target price (down from $29.00) on shares of K2M Group in a research note on Monday, October 9th. They noted that the move was a valuation call. Royal Bank Of Canada reaffirmed a “buy” rating and set a $26.00 price objective on shares of K2M Group in a research report on Friday, September 22nd. Oppenheimer reaffirmed a “buy” rating and set a $24.00 price objective on shares of K2M Group in a research report on Friday, November 10th. UBS reaffirmed a “buy” rating and set a $24.00 price objective (down from $26.00) on shares of K2M Group in a research report on Tuesday, October 10th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $28.00 price objective on shares of K2M Group in a research report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. K2M Group currently has an average rating of “Buy” and a consensus price target of $25.00.

K2M Group Holdings, Inc. (NASDAQ KTWO) opened at $18.93 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.67 and a current ratio of 3.06. K2M Group Holdings, Inc. has a 52-week low of $17.23 and a 52-week high of $25.99.

K2M Group (NASDAQ:KTWO) last posted its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.01). The firm had revenue of $62.65 million for the quarter, compared to analyst estimates of $62.69 million. K2M Group had a negative return on equity of 16.02% and a negative net margin of 16.22%. The firm’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the prior year, the company earned ($0.19) earnings per share. analysts anticipate that K2M Group Holdings, Inc. will post -0.86 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.watchlistnews.com/k2m-group-holdings-inc-ktwo-shares-bought-by-schroder-investment-management-group/1740574.html.

K2M Group Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Institutional Ownership by Quarter for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.